09:51 AM EST - Response Biomedical Corp. : announced that its existing Chinese Distribution Agreement with O&D Biotech Co., Ltd., dated February 21, 2011, as amended, has expired effective December 31, 2013. The Company is currently in discussions with O&D regarding a new agreement whereby O&D could continue to market Response's cardiovascular products under their own brand labels and registrations; however, there can be no assurance that a new agreement will be executed. Response Biomedical Corp.
shares T.RBM are trading unchanged at $1.56.
